News-Medical.Net on MSN
Dual-responsive nanodelivery system enhances immunotherapy efficacy in metastatic bladder cancer
Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and ...
The partners will use 4D Path's imaging-based Q-Plasia OncoReader in a Phase II trial testing doublet and triplet regimens comprising Trodelvy, Padcev, and Keytruda.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results